Table 3.
Measures of fetal growth in the Control and PR fetuses
| Control (n = 11) | Control + VEGF (n = 9) | PR (n = 8) | PR + VEGF (n = 5) | |
|---|---|---|---|---|
| Gestational age at post mortem (days) | 132 ± 1 | 133 ± 1 | 133 ± 1 | 132± 1 |
| Fetal weight (kg) | 3.66 ± 0.11 | 3.68 ± 0.23 | 2.92 ± 0.30† | 3.21± 0.33† |
| Crown rump length (cm) | 50.3 ± 1.6 | 54.3 ± 0.6* | 46.8 ± 1.7† | 50.3 ± 2.1*, † |
| Abdominal circumference (cm) | 34.0 ± 0.7 | 35.0 ± 0.8 | 31.7 ± 1.6† | 32.4 ± 1.1† |
| Relative brain weight (g kg–1) | 15.1 ± 0.4 | 13.5 ± 0.4 | 17.3 ± 0.9† | 15.9 ± 1.5† |
| Relative brain to liver weight ratio | 0.63 ± 0.04 | 0.56 ± 0.04 | 0.74 ± 0.07† | 0.71 ± 0.07† |
| Relative lung weight (g kg–1) | 31.4 ± 1.6 | 33.0 ± 2.2 | 33.5 ± 1.7† | 39.3 ± 3.0† |
Data (mean ± SEM) were analysed by two‐way ANOVA for treatment (Control vs. PR) and drug (Saline vs. VEGF). P < 0.05 was considered statistically significant. † P < 0.05 from Control fetuses (i.e. treatment effect); *P < 0.05 from Control and PR (i.e. drug effect).